2.02 USD
↗ 0.06 (2.86%)LIVE (AS OF 03:21 PM EDT)
Serina Therapeutics, Inc.
SERAMEX • USD
Market: OPEN
Serina Therapeutics, Inc. (SER) is currently trading at $2.02. Technical and fundamental signals converge bearish — technicals rate "Sell" while fundamentals read "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Oct 2, 2026.
Open?$2.10
High?$2.37
Low?$2.01
Prev. Close?$1.96
Volume?21.5K
Avg. Volume?81.3K
VWAP?$2.05
Rel. Volume?0.26x
Bid / Ask
Bid?$2.05 × 100
Ask?$2.03 × 100
Spread?-$0.02
Midpoint?$2.04
Valuation & Ratios
Market Cap?49.8M
Shares Out?25.4M
Float?7.2M
Float %?48.2%
P/E Ratio?N/A
P/B Ratio?2.66
EPS?-$0.95
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The company has one reportable segment relating to the research and development of its POZ platform. The segment derives its revenues from Grant revenue. Its main product candidate, SER-252 for advanced Parkinson's disease, is anticipated to enter clinical trials.
Employees
16
Market Cap
49.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2024-03-27
Address
601 GENOME WAY
HUNTSVILLE, AL 35806
Phone: (256) 327-9630
HUNTSVILLE, AL 35806
Phone: (256) 327-9630
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?65
Short Sent.?60
Piotroski F-Score?0/9Weak
Altman Z-Score?-2.24Distress
Confidence?49%Low
Short InterestLow
Short % of Float?1.65%Low
Short Interest?119.4K
Days to Cover?1.4
Free Float7.2M
Avg Daily Volume82.9K
Settlement Date2026-09-15
Financial Health
Current Ratio?6.65Strong
Quick Ratio?6.65Strong
Cash Ratio?6.12Strong
Debt/Equity?0.16Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.66CHEAP▾
Peers100
S&P61
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.2CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-128.4%WEAK▾
S&P3
ROA?-93.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-21201000
Enterprise Value?$29.8M
Fundamentals ratios updated end of day